Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
[ad_1] Australian biopharma company developing therapeutic cannabinoid products and psychedelic medicines Incannex Healthcare IXHL announced that its Phase 2 clinical trial assessing proprietary psilocybin-assisted psychotherapy for Generalized Anxiety Disorder (GAD)…